Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease

References

• KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1–S13.
   Google Scholar
• Schlieper G, Krüger T, Djuric Z, et al. Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int. 2008;74(12):1582–1587. doi: 10.1038/ki.2008.458.
   PubMed Web of Science ®Google Scholar
• Jankowski J, Floege J, Fliser D, et al. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–1172. doi: 10.1161/CIRCULATIONAHA.120.050686.
   PubMed Web of Science ®Google Scholar
• Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014;307(8):F891–F900. doi: 10.1152/ajprenal.00163.2014.
   PubMed Web of Science ®Google Scholar
• Chen J, Budoff MJ, Reilly MP, et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2017;2(6):635–643. doi: 10.1001/jamacardio.2017.0363.
   PubMed Web of Science ®Google Scholar
• Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422–430. doi: 10.7326/M17-2640.
   PubMed Web of Science ®Google Scholar
• Neven E, Dams G, Postnov A, et al. Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats. Nephrol Dial Transplant. 2009;24(6):1790–1799. doi: 10.1093/ndt/gfn737.
   PubMed Web of Science ®Google Scholar
• De Schutter TM, Behets GJ, Geryl H, et al. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int. 2013;83(6):1109–1117. doi: 10.1038/ki.2013.34.
   PubMed Web of Science ®Google Scholar
• Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815–1824. doi: 10.1111/j.1523-1755.2005.00600.x.
   PubMed Web of Science ®Google Scholar
• Reiss AB, Miyawaki N, Moon J, et al. CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies. Atherosclerosis. 2018;278:49–59. doi: 10.1016/j.atherosclerosis.2018.08.046.
   PubMed Web of Science ®Google Scholar
• Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone. 2017;100:87–93. doi: 10.1016/j.bone.2016.11.012.
   PubMed Web of Science ®Google Scholar
• Leopold JA. Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2015;25(4):267–274. doi: 10.1016/j.tcm.2014.10.021.
   PubMed Web of Science ®Google Scholar
• Chinetti-Gbaguidi G, Daoudi M, Rosa M, et al. Human alternative macrophages populate calcified areas of atherosclerotic lesions and display impaired RANKL-induced osteoclastic bone resorption activity. Circ Res. 2017;121(1):19–30. doi: 10.1161/CIRCRESAHA.116.310262.
   PubMed Web of Science ®Google Scholar
• Zazzeroni L, Faggioli G, Pasquinelli G. Mechanisms of arterial calcification: the role of matrix vesicles. Eur J Vasc Endovasc Surg. 2018;55(3):425–432. doi: 10.1016/j.ejvs.2017.12.009.
   PubMed Web of Science ®Google Scholar
• Kapustin AN, Chatrou ML, Drozdov I, et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res. 2015;116(8):1312–1323. doi: 10.1161/CIRCRESAHA.116.305012.
   PubMed Web of Science ®Google Scholar
• Yang L, Dai R, Wu H, et al. Unspliced XBP1 counteracts β-Catenin to inhibit vascular calcification. Circ Res. 2022;130(2):213–229. doi: 10.1161/CIRCRESAHA.121.319745.
   PubMed Web of Science ®Google Scholar
• Pang Q, Wang P, Pan Y, et al. Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. Cell Death Dis. 2022;13(3):283. doi: 10.1038/s41419-022-04735-7.
   PubMed Web of Science ®Google Scholar
• De Maré A, Opdebeeck B, Neven E, et al. Sclerostin protects against vascular calcification development in mice. J Bone Miner Res. 2022;37(4):687–699. doi: 10.1002/jbmr.4503.
   PubMed Web of Science ®Google Scholar
• Wang PW, Pang Q, Zhou T, et al. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease. Atherosclerosis. 2022;346:36–45. doi: 10.1016/j.atherosclerosis.2022.02.007.
   PubMed Web of Science ®Google Scholar
• Arase H, Yamada S, Torisu K, et al. Protective roles of xenotropic and polytropic retrovirus receptor 1 (XPR1) in uremic vascular calcification. Calcif Tissue Int. 2022;110(6):685–697. doi: 10.1007/s00223-022-00947-3.
   PubMed Web of Science ®Google Scholar
• Xie C, Chen C, Wu L, et al. BRCC36 prevents vascular calcification in chronic kidney disease through the β-catenin signalling pathway. Exp Cell Res. 2022;413(1):113051. doi: 10.1016/j.yexcr.2022.113051.
   PubMed Web of Science ®Google Scholar
• Tóth A, Csiki DM, Nagy BJ, et al. Daprodustat accelerates high phosphate-induced calcification through the activation of HIF-1 signaling. Front Pharmacol. 2022;13:798053. doi: 10.3389/fphar.2022.798053.
   PubMed Web of Science ®Google Scholar
• Oe Y, Mitsui S, Sato E, et al. Lack of endothelial nitric oxide synthase accelerates ectopic calcification in uremic mice fed an adenine and high phosphorus diet. Am J Pathol. 2021;191(2):283–293. doi: 10.1016/j.ajpath.2020.10.012.
   PubMed Web of Science ®Google Scholar
• He W, Huang J, Liu Y, et al. Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring sirtuin 3 expression. Cell Death Dis. 2021;12(11):992. doi: 10.1038/s41419-021-04283-6.
   PubMed Web of Science ®Google Scholar
• Su Z, Zong P, Chen J, et al. Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling. J Cell Mol Med. 2020;24(21):12476–12490. doi: 10.1111/jcmm.15779.
   PubMed Web of Science ®Google Scholar
• Tani T, Fujiwara M, Orimo H, et al. Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model. J Pathol. 2020;250(1):30–41. doi: 10.1002/path.5346.
   PubMed Web of Science ®Google Scholar
• Huang LH, Liu H, Chen JY, et al. Seaweed porphyra yezoensis polysaccharides with different molecular weights inhibit hydroxyapatite damage and osteoblast differentiation of A7R5 cells. Food Funct. 2020;11(4):3393–3409. doi: 10.1039/c9fo01732a.
   PubMed Web of Science ®Google Scholar
• Kukida M, Mogi M, Kan-No H, et al. AT2 receptor stimulation inhibits phosphate-induced vascular calcification. Kidney Int. 2019;95(1):138–148. doi: 10.1016/j.kint.2018.07.028.
   PubMed Web of Science ®Google Scholar
• Nguyen-Yamamoto L, Tanaka KI, St-Arnaud R, et al. Vitamin D-regulated osteocytic sclerostin and BMP2 modulate uremic extraskeletal calcification. JCI Insight. 2019;4(13):e126467. doi: 10.1172/jci.insight.126467.
   PubMed Web of Science ®Google Scholar
• Clinkenbeard EL, Noonan ML, Thomas JC, et al. Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD. JCI Insight. 2019;4(4):e123817. doi: 10.1172/jci.insight.123817.
   PubMed Web of Science ®Google Scholar
• Li XY, Li QM, Fang Q, et al. Laminaria japonica polysaccharide inhibits vascular calcification via preventing osteoblastic differentiation of vascular smooth muscle cells. J Agric Food Chem. 2018;66(8):1821–1827. doi: 10.1021/acs.jafc.7b06115.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Yamashita M, Horimai C, et al. Smooth muscle-selective nuclear factor-κB inhibition reduces phosphate-induced arterial medial calcification in mice with chronic kidney disease. J Am Heart Assoc. 2017;6(11):e007248.
   Web of Science ®Google Scholar
• Tani T, Orimo H, Shimizu A, et al. Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease. Sci Rep. 2017;7(1):2233. doi: 10.1038/s41598-017-02351-6.
   PubMedGoogle Scholar
• Gao C, Fu Y, Li Y, et al. Microsomal prostaglandin E synthase-1-derived PGE2 inhibits vascular smooth muscle cell calcification. Arterioscler Thromb Vasc Biol. 2016;36(1):108–121. doi: 10.1161/ATVBAHA.115.306642.
   PubMed Web of Science ®Google Scholar
• Biltz RM, Pellegrino ED. The chemical anatomy of bone. I. A comparative study of bone composition in sixteen vertebrates. J Bone Joint Surg Am. 1969;51(3):456–466. doi: 10.2106/00004623-196951030-00003.
   PubMed Web of Science ®Google Scholar
• Bertazzo S, Gentleman E, Cloyd KL, et al. Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater. 2013;12(6):576–583. doi: 10.1038/nmat3627.
   PubMed Web of Science ®Google Scholar
• Laclair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45(6):1026–1033. doi: 10.1053/j.ajkd.2005.02.029.
   PubMed Web of Science ®Google Scholar
• Melamed ML, Chonchol M, Gutiérrez OM, et al. The role of vitamin D in CKD stages 3 to 4: report of a scientific workshop sponsored by the national kidney foundation. Am J Kidney Dis. 2018;72(6):834–845. doi: 10.1053/j.ajkd.2018.06.031.
   PubMed Web of Science ®Google Scholar
• Morrison AB. Experimentally induced chronic renal insufficiency in the rat. Lab Invest. 1962;11:321–332.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Zheng PD, Oura H, et al. Animal model of adenine-induced chronic renal failure in rats. Nephron. 1986;44(3):230–234. doi: 10.1159/000183992.
   PubMed Web of Science ®Google Scholar
• Kim K, Anderson EM, Thome T, et al. Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice. Am J Physiol Renal Physiol. 2021;321(1):F106–F119. doi: 10.1152/ajprenal.00117.2021.
   PubMed Web of Science ®Google Scholar
• Mcrobb LS, Mcgrath K, Tsatralis T, et al. Estrogen receptor control of atherosclerotic calcification and smooth muscle cell osteogenic differentiation. Arterioscler Thromb Vasc Biol. 2017;37(6):1127–1137. doi: 10.1161/ATVBAHA.117.309054.
   PubMed Web of Science ®Google Scholar
• Osako MK, Nakagami H, Koibuchi N, et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res. 2010;107(4):466–475. doi: 10.1161/CIRCRESAHA.110.216846.
   PubMed Web of Science ®Google Scholar
• Ivandic BT, Utz HF, Kaczmarek PM, et al. New dyscalc loci for myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Physiol Genomics. 2001;6(3):137–144. doi: 10.1152/physiolgenomics.2001.6.3.137.
   PubMed Web of Science ®Google Scholar
• Troxell ML, Higgins JP, Sibley RK. Glomerular and tubular basement membrane calcinosis: case report and literature review. Am J Kidney Dis. 2006;47(2):e23–e26. doi: 10.1053/j.ajkd.2005.10.030.
   PubMed Web of Science ®Google Scholar
• Mulligan RM. Metastatic calcification. Arch Pathol. 1947;43(2):177–230.
   Google Scholar
• Trillo A, Orozco R, Jindal K. Glomerular calcinosis in sarcoidosis. Arch Pathol Lab Med. 1992;116(11):1221–1225.
   PubMed Web of Science ®Google Scholar
• Fellner SK, Spargo BH. Nephrotic syndrome from hypercalcemia in a patient with primary hyperparathyroidism. Am J Med. 1987;83(2):355–358. doi: 10.1016/0002-9343(87)90712-1.
   PubMed Web of Science ®Google Scholar
• Ross L, Wing C. Metastatic calcification of renal glomerular basement-membrane. J Pathol. 1970;101(1):69–71. doi: 10.1002/path.1711010113.
   PubMed Web of Science ®Google Scholar
• Henegar JR, Coleman JP, Cespedes J, et al. Glomerular calcification in hypercalcemic nephropathy. Arch Pathol Lab Med. 2003;127(2):E80–E85. doi: 10.5858/2003-127-e80-GCIH.
   PubMedGoogle Scholar